The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of sodium‐glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions

Published:2019-08-10 Issue:5 Volume:6 Page:927-935
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Lan Nick S.R.¹,Fegan P. Gerry¹,Yeap Bu B.¹²,Dwivedi Girish²³

Affiliation:

1. Department of Endocrinology and DiabetesFiona Stanley Hospital Murdoch Western Australia Australia

2. The Medical SchoolThe University of Western Australia Perth Western Australia Australia

3. Department of CardiologyFiona Stanley Hospital Murdoch Western Australia Australia

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12505

Reference50 articles.

1. Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences

2. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

4. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

5. Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sex on sodium‐glucose co‐transporter‐2 antagonists and glucagon‐like peptide‐1 agonists in heart failure;ESC Heart Failure;2024-07-23

2. Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure;Cardiovascular Diabetology;2024-06-07

3. Effects of SGLT2 inhibitors on right ventricular function in heart failure patients: Updated meta-analysis of the current literature;Polish Heart Journal;2024-04-30

4. Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure;2024-03-25

5. Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome;Acta Cardiologica;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3